These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9613341)

  • 1. Effects of moderate renal insufficiency on pharmacokinetics of methotrexate in rheumatoid arthritis patients.
    Bressolle F; Bologna C; Kinowski JM; Sany J; Combe B
    Ann Rheum Dis; 1998 Feb; 57(2):110-3. PubMed ID: 9613341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and free methotrexate pharmacokinetics in rheumatoid arthritis patients.
    Edno L; Bressolle F; Gomeni R; Bologna C; Sany J; Combe B
    Ther Drug Monit; 1996 Apr; 18(2):128-34. PubMed ID: 8721274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
    Bressolle F; Bologna C; Kinowski JM; Arcos B; Sany J; Combe B
    J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells.
    Korell J; Stamp LK; Barclay ML; Dalrymple JM; Drake J; Zhang M; Duffull SB
    Clin Pharmacokinet; 2013 Jun; 52(6):475-85. PubMed ID: 23483363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
    Kremer JM; Hamilton RA
    J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
    Odderskov C; Stengaard-Pedersen K; Ellingsen T; Hornung N
    Scand J Clin Lab Invest; 2020 May; 80(3):185-190. PubMed ID: 31876200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pregabalin in subjects with various degrees of renal function.
    Randinitis EJ; Posvar EL; Alvey CW; Sedman AJ; Cook JA; Bockbrader HN
    J Clin Pharmacol; 2003 Mar; 43(3):277-83. PubMed ID: 12638396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis.
    Hübner G; Sander O; Degner FL; Türck D; Rau R
    J Rheumatol; 1997 May; 24(5):845-51. PubMed ID: 9150070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
    J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
    Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
    Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing methotrexate and methotrexate polyglutamate in patients with rheumatoid arthritis: a systematic review of population pharmacokinetics.
    Methaneethorn J; AlEjielat R; Leelakanok N
    Drug Metab Pers Ther; 2022 Sep; 37(3):229-240. PubMed ID: 35218177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proof-of-concept and drug-drug interaction study of pamapimod, a novel p38 MAP kinase inhibitor, with methotrexate in patients with rheumatoid arthritis.
    Zhang X; Huang Y; Navarro MT; Hisoire G; Caulfield JP
    J Clin Pharmacol; 2010 Sep; 50(9):1031-8. PubMed ID: 20100913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.